E20 Capital’s UnitedHealth UNH Stock Holding History

E20 Capital’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,690	Closed	-$8.81M	–	30
2025 Q4	$8.81M	Buy	+26,690	New	+$9.04M	3.18%	10

Other funds holding UNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

E20 Capital's UNH Position: Q1 2026 in Review

E20 Capital sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 26,690 shares — an estimated $8.81M sold.

E20 Capital first reported a position in UNH in Q4 2025 and held it in 1 quarter. The position peaked at $8.81M in Q4 2025. 3,045 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

E20 Capital reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
E20 Capital sold 26,690 UnitedHealth shares in Q1 2026, an estimated $8.81M.
E20 Capital first reported a position in UnitedHealth in Q4 2025 and held it in 1 quarter.
E20 Capital's UnitedHealth position peaked at $8.81M in Q4 2025.
3,045 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on E20 Capital's 13F filing for Q1 2026, filed 20 May 2026.